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ABSTRACT G protein-gated inward rectifier K1 (GIRK)
channels mediate hyperpolarizing postsynaptic potentials in
the nervous system and in the heart during activation of
Ga(iyo)-coupled receptors. In neurons and cardiac atrial cells
the time course for receptor-mediated GIRK current deacti-
vation is 20–40 times faster than that observed in heterolo-
gous systems expressing cloned receptors and GIRK channels,
suggesting that an additional component(s) is required to
confer the rapid kinetic properties of the native transduction
pathway. We report here that heterologous expression of
‘‘regulators of G protein signaling’’ (RGS proteins), along
with cloned G protein-coupled receptors and GIRK channels,
reconstitutes the temporal properties of the native receptor3
GIRK signal transduction pathway. GIRK current waveforms
evoked by agonist activation of muscarinic m2 receptors or
serotonin 1A receptors were dramatically accelerated by co-
expression of either RGS1, RGS3, or RGS4, but not RGS2. For
the brain-expressed RGS4 isoform, neither the current am-
plitude nor the steady-state agonist dose-response relation-
ship was significantly affected by RGS expression, although
the agonist-independent ‘‘basal’’ GIRK current was sup-
pressed by '40%. Because GIRK activation and deactivation
kinetics are the limiting rates for the onset and termination of
‘‘slow’’ postsynaptic inhibitory currents in neurons and atrial
cells, RGS proteins may play crucial roles in the timing of
information transfer within the brain and to peripheral
tissues.
Regulators of G protein signaling (RGS proteins) are members
of a novel multigene family (1–3) that accelerate the GTPase
rate of heterotrimeric Ga(iyo) proteins through direct inter-
action (4–6). These GTPase-activating proteins (GAPs) have
generated recent interest because of well-established discrep-
ancies between the in vitro GTPase rate of purified Ga
subunits and the much greater (typically .40-fold) in vivo rate
at which some G protein-mediated signals are terminated (7).
For instance, in the G protein signaling cascade of visual
phototransduction (8, 9), RGS proteins may help to produce
the rapid signal termination necessary for processing visual
stimuli at a high temporal resolution (10).
An analogous kinetic discrepancy exists for the Gbg-
activated inward rectifier K1 (GIRK) channel in atrial myo-
cytes (11, 12). Muscarinic m2 receptor-activated GIRK cur-
rents deactivate after agonist washout '40-fold faster (1ytdeact
' 2 s21) than the GTP hydrolysis rate of pertussis toxin-
sensitive Ga subunits (kcat ' 0.05 s21). Yet these Ga(iyo)
subunits are thought to terminate the current by resequester-
ing Gbg dimers after returning to their GDP-bound state (12).
GIRK channels expressed in CA3 hippocampal neurons dis-
play a similar rapid deactivation (13). However, cloned GIRK
channels expressed in Xenopus oocytes with the m2 receptor
deactivate with a rate constant that is nearly equivalent ('0.05
s21) to the intrinsic Ga subunit GTPase rate constant (14).
Thus, atrial myocytes and hippocampal neurons, but not
Xenopus oocytes, may express one or more GAPs that accel-
erate GIRK kinetics. The slowing of atrial GIRK current
deactivation in excised membrane patches provides additional
evidence for an extrinsic GAP-like component (15).
Here we demonstrate that when cloned GIRK channels and
the muscarinic m2 receptor are coexpressed with certain RGS
proteins in Xenopus oocytes or Chinese hamster ovary (CHO)
cells, receptor-evoked GIRK current kinetics are accelerated
and mimic the properties of GIRK currents in native atrial
myocytes and hippocampal neurons. These results suggest that
endogenous RGS proteins in atrial myocytes and neurons are
important factors that affect the temporal gating properties of
GIRK channels. Moreover, RGS proteins accelerated the
GIRK activation phase as well as the deactivation phase
without affecting the EC50 value for activation by acetylcholine
(ACh), raising new mechanistic questions regarding the inter-
play of receptors, Gbg dimers, Ga subunits, and RGS proteins
in GIRK channel gating. The physiological implications of
these findings are that RGS proteins may determine the
timing, amplitude, and duration of GIRK-mediated ‘‘slow’’
inhibitory synaptic transmission in the nervous system.
MATERIALS AND METHODS
RGS cDNAs. Reverse transcription and PCR amplification
were used to clone RGS4 from rat brain RNA using the




The PCR product was cut with EcoRI and XbaI and cloned
into the pcDNA3.1(1) plasmid (Invitrogen). The entire nu-
cleotide sequence of the cloned insert was verified (California
Institute of Technology DNA Sequencing Facility) as identical
to rat brain RGS4 (GenBank accession no. U27767). Follow-
ing initial studies on the effects of RGS4, cDNAs for human
RGS1, RGS2, and RGS3 (kindly provided by K. Druey and J.
Kehrl, National Institutes of Health) were subsequently ex-
amined.
Oocyte Electrophysiology. Stage V and VI oocytes from
Xenopus laevis were injected with various combinations of
cRNAs synthesized in vitro (Ambion, Austin, TX) from lin-
earized plasmids containing cDNAs for the m2 receptor (pro-
vided by E. Peralta, Harvard University), the serotonin (5-
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HT)1A receptor (provided by P. Hartig, Synaptic Pharmaceu-
tical), the Kir3.1 subunit (16), the Kir3.2 subunit (17), the
Kir3.4 subunit (provided by J. Adelman, Oregon Health
Sciences University), the b2-adrenergic receptor (b2-AR)
(provided by B. Kobilka, Stanford University), the Gas sub-
unit (provided by M. Simon, California Institute of Technol-
ogy), and the RGS isoforms. For most experiments, oocytes
were injected (final volume 50 nl) with 0.5 ng cRNA each for
the m2 receptor, Kir3.1, and Kir3.2, with and without the
addition of 10 ng of RGS cRNA. For the b2-AR experiments,
0.5 ng of b2-AR and 5 ng Gas cRNAs were included (22).
Injected oocytes were maintained overnight at 19°C in the
following solution: 96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1
mM MgCl2, 5 mM Hepes, 2.5 mM sodium pyruvate, 0.5 mM
theophylline, 50 mgyml gentamicin (pH 7.5).
Two-electrode voltage clamping of Xenopus oocytes was
performed the day after cRNA injection as described in detail
(18). The holding potential was 280 mV, and inward GIRK
currents were recorded in a solution composed of 20 mM KCl,
78 mM NaCl, 1 mM MgCl2, and 5 mM Hepes at pH 7.5. A
U-tube superfusion apparatus was used to minimize agonist
application and washout times. Analysis of the GIRK current
kinetics was performed using PCLAMP 6.0 software.
Mammalian Cell Culture and cDNA Transfection. Adult rat
atrial myocytes were isolated as described (19). Atrial cells and
CHO-K1 cells (American Type Culture Collection) were
plated in 35-mm dishes and grown in a-MEM supplemented
with 5% fetal bovine serum and 100 unitsyml penicillin and
100 mgyml streptomycin. For transfection of CHO-K1 cells,
lipofectamine (GIBCO, 3 ml per dish) was mixed with the
following cDNAs cloned in the mammalian expression vector
pcDNA3.1(1) (Invitrogen): 0.2 mg m2 receptor, 0.2 mg Kir3.1,
0.2 mg Kir3.2, and in some cases 0.2 mg RGS4. In all cases, 0.1
mg green fluorescent protein cDNA (GIBCO) was included as
a reporter. CHO cells were then incubated in serum-free
media Opti-MEM1 (GIBCO) for 16–18 h. Electrophysiolog-
ical recordings from CHO cells were made 24–36 h from the
start of the transfection on green fluorescent protein positive
cells.
Electrophysiological Recording from Mammalian Cells.
Currents were recorded using the whole-cell voltage clamp
configuration (20). Pipettes were pulled from borosilicate glass
and fire-polished to a final resistance of 3–5 MV. Solution
exchanges were accomplished with a DAD-12 perfusion sys-
tem (Adams and List, Westbury, NY) with a time constant of
100 ms. Voltage protocols were generated and the data were
digitized, recorded, and analyzed using PCLAMP 6.0 (Axon
Instruments, Foster City, CA). Junction potentials were un-
corrected and amounted to ,3 mV. The pipette solution
contained 130 mM potassium aspartate, 20 mM KCl, 1 mM
MgCl2, 5 mM EGTA, 5 mM Hepes, 0.1 mM Na2GTP, and 2.5
mM MgATP (pH 7.3) (with NaOH). The external solution
contained 111.5 mM NaCl, 30.4 mM KCl, 1.8 mM CaCl2, 0.53
mM MgCl2, and 5 mM Hepes (pH 7.3). All recordings were
made at 20–23°C.
RESULTS
RGS Proteins Accelerate GIRK Deactivation and Activation
Kinetics. ACh-evoked GIRK currents recorded from Xenopus
oocytes expressing muscarinic m2 receptors and Kir3.1yKir3.2
channels [mimicking the probable heteromultimeric state of
some native neuronal GIRK channels (17)] deactivate with a
time course well described by a single time constant of '20 s
(Fig. 1). This time constant agrees with earlier measurements
of Kir3.1yKir3.4 channels [mimicking the heteromultimeric
FIG. 1. Effects of RGS1–4 on the temporal and steady-state properties of m2 receptor-evoked GIRK currents recorded from Xenopus oocytes.
(a) Representative traces of ACh-evoked GIRK currents (Kir3.1yKir3.2) recorded from oocytes not expressing (Control) or expressing RGS4
(1RGS4). (b Top) Deactivation time constants (tdeact) derived from exponential fits to the GIRK current deactivation phase from ‘‘Control’’ oocytes
(i.e., not injected with RGS cRNA) or oocytes injected with cRNA (10 ng) for RGS1, RGS2, RGS3, or RGS4. (Middle) Activation time constants
(tact) derived from exponential fits of the GIRK activation phase in oocytes expressing the various RGS proteins. (Lower) Effects of RGS proteins
on ‘‘basal’’ GIRK currents (IK,basal, open bars) measured as the inward current induced by changing the external [K1] from 0 to 20 mM. Solid bars
are the amplitudes of inward GIRK currents induced by 1 mM ACh (IK,ACh) in 20 mM external [K1]. All bars are the mean 6 SEM from 12–15
oocytes from the same three batches.
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state of atrial GIRK channels (14, 21)]. Coexpression of RGS1,
RGS3, or RGS4 resulted in accelerated GIRK currents that
rapidly deactivated (Fig. 1), with time constants of '4 s. RGS2,
however, had no significant effect on the GIRK current
waveform.
Interestingly, the time course for GIRK activation was also
briefer in oocytes expressing RGS1, RGS3, or RGS4, but not
RGS2 (Fig. 1). The GIRK activation rate was affected to a
similar extent for the three effective RGS proteins, being
'2-fold faster than control or RGS2-expressing oocytes (Fig.
1b); however, the measurements may be limited by the time for
solution change (t ' 1 s). Associated with the RGS-
accelerated GIRK activation phase was a significant decay of
the current (i.e., desensitization) during a brief (10 s) agonist
pulse (Fig. 1). If such desensitization also occurs in the absence
of RGS, it would be obscured by the slow rise time of the
responses. Although we did not systematically examine the
effects of RGS expression on GIRK desensitization, experi-
ments using longer agonist applications indicated that the rate
and extent of desensitization on a time scale of minutes were
not significantly affected by RGS expression. RGS4 similarly
affected the activation and deactivation time courses of ex-
pressed Kir3.1yKir3.4 channels, suggesting that the kinetic
effects of RGS proteins do not depend strongly on GIRK
subunit composition (data not shown).
RGS Proteins Suppress ‘‘Basal’’ GIRK Activity. Coexpres-
sion of RGS proteins did not significantly affect the amplitude
of ACh-evoked GIRK currents (IK,ACh), although the large
variations among oocytes may have hidden subtle effects of
RGS expression (Fig. 1b). Agonist independent ‘‘basal’’ GIRK
currents (IK,basal), however, were significantly reduced by
RGS1 and RGS4 (Fig. 1b). For RGS1, IK,basal was reduced
nearly 60% (control: 21.40 6 0.32 mA, 1RGS1: 20.57 6 0.12
mA; mean 6 SEM, n 5 14 oocytes paired from three different
batches). For RGS4, IK,basal was reduced '42% (control:
21.26 6 0.24 mA, 1RGS4: 20.73 6 0.11 mA; mean 6 SEM,
n 5 22–23 oocytes paired from five different batches).
RGS4 Does Not Affect the ACh Dose-Response Relation.
The effects of RGS4 on m2 receptor-evoked GIRK currents
were examined over a wide range of ACh concentrations (1029
to 1025 M) (Fig. 2). GIRK deactivation time constants were
roughly constant for currents evoked over the entire concen-
tration range, and RGS expression reduced these time con-
stants by 5- to 10-fold, with no systematic concentration
dependence. As expected, the GIRK activation time constant
was dependent on ACh concentration, and RGS4 reduced the
time constant by roughly 2-fold at all concentrations (Fig. 2).
Surprisingly, the steady-state ACh dose-response relation for
GIRK current activation was not altered by coexpression of
RGS4 (Fig. 2); the EC50 value for ACh was '50 nM, with or
without RGS4 expression.
Ga Subunit and Receptor Specificity. RGS1 and RGS4 do
not affect the GTPase rate of Gas subunits in vitro (4–6). To
test the Ga specificity of the RGS effect on GIRK kinetics, we
examined the effects of RGS4 on GIRK currents activated by
a coexpressed Gas-coupled receptor, the b2-AR (22). In
oocytes coexpressing both the m2 receptor and b2-AR, RGS4
expression markedly accelerated ACh-evoked GIRK re-
sponses, both in the activation phase (by '2-fold) and the
deactivation phase, as in oocytes not expressing the b2-AR (cf.
Fig. 2). There was no significant effect on the activation time
course for the b2-AR-evoked currents. The deactivation time
course of isoproterenol-evoked GIRK currents (Fig. 3) was
only slightly briefer. Interestingly, the deactivation time course
of isoproterenol-evoked GIRK currents displayed a significant
lag phase prior to the current decay (22). The small but
significant shortening of the isoproterenol-evoked GIRK de-
activation by RGS4 may arise from one of two mechanisms
that are consistent with a specific action of RGS4 on Ga(iyo).
(i) An increased Ga(iyo) subunit GTPase rate in the absence
of m2R activation is inferred from the RGS4-mediated reduc-
tion in basal GIRK activity (see Fig. 1). This implies a raised
level of Ga(iyo)-GDP, which would be available to sequester
Gbg from b2-AR-activated GIRK channel, thereby promoting
faster deactivation. (ii) b2-ARs might activate GIRK channels
in part via promiscuous coupling to Ga(iyo).
To test whether the RGS isoforms differentially affected
GIRK channels activated by a different Ga(iyo)-coupled
receptor, we examined the effects of RGS1–4 on 5-HT-evoked
GIRK currents in oocytes coexpressing the 5-HT1A receptor
together with the m2 receptor. In data not shown, 5-HT-evoked
GIRK currents showed RGS-mediated effects and a profile
(i.e., accelerated activation and deactivation by RGS1, RGS3,
and RGS4) resembling the data for the ACh-evoked GIRK
currents, indicating that RGS proteins show no specificity
between m2 receptors and 5-HT1A receptors.
FIG. 2. ACh dose-effect relations for kinetic and steady-state
GIRK gating properties. (Top) Deactivation time constants derived
from exponential fits to the GIRK currents after washout of various
ACh concentrations. Solid circles are values without RGS4 expression;
open circles are with RGS4 expression (mean 6 SEM from four
oocytes of the same batch). (Middle) Activation time constant of
ACh-evoked GIRK currents as a function of ACh concentration with
(open circle) and without (solid circle) coexpression of RGS4. The
time course for GIRK activation was fit with an exponential function
plus a sloping base line. (Lower) Steady-state ACh dose-response
curve for GIRK responses with (open circles) and without (solid
circles) RGS4 expression. Current amplitudes were normalized to the
currents evoked by 10 mM ACh for each cell (1–2 mA) and are from
the same records used to derive the kinetic data shown in Top and
Middle. The data (solid circles) were fitted with a Hill function (solid
line) having an EC50 value of 48 nM.
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RGS4-Accelerated GIRK Currents Mimic Native GIRK
Current Kinetics. We also examined the effects of RGS4
cotransfected into CHO-K1 cells with the m2 receptor, Kir3.1,
and Kir3.2 (Fig. 4). For these experiments we used a super-
fusion system capable of changing external solutions with a
time constant of ,100 ms, compared with the possibly limiting
exchange rate in the oocyte experiments (t '1–2 s). In cells not
expressing RGS4, the ACh-evoked currents deactivated with
time constants of ' 9 s (Fig. 4a); in cells cotransfected with
RGS4, the deactivation time constants ranged from 0.5 to 1 s.
Moreover, with RGS4 present, the GIRK deactivation rates
were equivalent to the deactivation rates of native GIRK
current recorded from cultured rat atrial cells (Fig. 4a).
For the GIRK activation phase with coexpressed RGS4, a
brief lag time (,50 ms) followed by a time constant ,1 s (Fig.
4b) closely matches the activation time course for atrial
muscarinic responses (23, 24) and g-aminobutyric acid type B
responses in hippocampal neurons (13). The activation rate
was agonist dependent and accelerated by RGS4 to an extent
similar to that observed in oocytes (Fig. 4b). ACh dose-
response relations yielded an EC50 value of '300 nM in the
presence of RGS4, which agreed within 2-fold with measure-
ments in the absence of RGS4 (data not shown).
Effect of RGS Expression on GIRK Currents Evoked by
Brief Agonist Pulses. The consequences of the RGS acceler-
ated kinetics for physiologically relevant brief agonist appli-
cations are illustrated in an experiment on CHO cells (Fig. 5).
The duration of ACh application was varied from 1 to 20 s.
With RGS4 expression, a 1-s application of 1 mM ACh leads
to full activation of the GIRK current. Without RGS4 expres-
sion, a 1-s application leads to a smaller amplitude but much
prolonged GIRK current waveform. Because of the acceler-
ated deactivation phase, the integrated K1 current (charge
movement) that flows for the 1 s application is '50% less with
RGS4 coexpression, reminiscent of the negative regulation
described for the yeast pheromone pathway (2, 25) and for
egg-laying behavior in Caenorhabditis elegans (3). These ex-
periments emphasize that for a brief agonist application, such
as during a single synaptic event, RGS4 would increase the
peak amplitude of GIRK currents in addition to accelerating
the decay phase upon removal of transmitter.
DISCUSSION
RGS Specificity and GIRK Channel Kinetics. The results of
this study demonstrate that coexpression of certain RGS
proteins (i.e., RGS1, RGS3, or RGS4) with GIRK channels
and Gaiyo-coupled receptors reconstitutes the rapid gating
characteristics of native atrial and neuronal GIRK currents.
Northern blot analysis indicates that RGS3 and RGS4 are
highly expressed in the heart and brain, respectively (2, 3), and
therefore are candidates for conferring the rapid kinetics of
atrial and neuronal GIRK channels. RGS1 on the other hand,
which was as effective as RGS3 and RGS4 in accelerating
GIRK currents in Xenopus oocytes, is a mitogen-activated
immediate–early gene expressed in B lymphocytes and not
detected in the heart or brain (26). RGS2, also an immediate–
early gene expressed in malignant hematopoietic and nonhe-
matopoietic cells (27), had no significant effect on GIRK
current waveforms. Recent experiments show that RGS2 does
not interact with Gai2, Gai3, or Gao subunits in vitro under
conditions (i.e., GDP-AlF4) that favor binding by RGS1,
RGS3, and RGS4 (28). Therefore, the lack of RGS2 effects on
GIRK kinetics may be explained by an inability to interact
effectively with Gaiyo subunits. The effect of RGS1 on GIRK
gating suggests that other RGS isoforms expressed in the heart
and brain (i.e., GAIP, RGS5, RGS7, RGS10), which interact
effectively with Gaiyo proteins, might also be expected to
accelerate GIRK channel gating.
Kinetic Anomalies Associated with RGS-Accelerated GIRK
Currents. In both Xenopus oocytes and CHO cells expression
of RGS4 dramatically accelerated GIRK activation as well as
deactivation. According to classical kinetic concepts, the ac-
celerated GIRK activation time course could occur even if the
only kinetic process(es) altered by RGS4 expression is the
deactivation of the GIRK conductance upon removal of the
agonist. We therefore analyzed the macroscopic GIRK acti-
vation and deactivation rates to ascertain whether the process-
(es) governing activation was affected to the same extent as
that for deactivation. Formally, we assumed a simple two-state
model (closed and open), where the rate constant for GIRK
current activation (1ytact) is equal to the sum of the macro-
scopic opening and closing rate constants, kopen and kclose,
respectively. The parameter kopen is expected to depend on the
agonist concentration; and the deactivation rate (1ytdeact)
gives kclose, which is measured upon agonist removal. Because
the macroscopic GIRK current relaxations are much slower
than the lifetime of single-channel openings (0.5 to 3.5 ms)
(17), kopen and kclose represent multistep processes that are
thought to control complex bursts of GIRK channel activity
(29). When these relations were used to calculate kopen, we
found that RGS4 expression had no effect on the GIRK
opening rate kopen in transfected CHO cells and only a 2-fold
FIG. 3. RGS4 selectively accelerates the gating of Ga(iyo) recep-
tor-coupled GIRK currents. Xenopus oocytes coexpressing the m2
receptor, b2-AR, Gas, Kir3.1, and Kir3.2 elicit GIRK currents in
response to either ACh (1 mM) or isoproterenol (1 mM). (Upper)
Superimposed ACh- and isoproterenol-evoked GIRK current records
are from the same oocyte either expressing (1RGS4) or not expressing
RGS4 (Control), and have been normalized for comparison. (Lower)
Summary of the deactivation half times (t1/2) for ACh-evoked and
b2-AR-evoked GIRK currents with (open bar) and without (solid bar)
RGS4 coexpression. (Bars are the mean 6 SEM from 6–10 oocytes
from two batches of oocytes.)
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increase in oocytes, in comparison with the 10- to 20-fold
increase in kclose for both expression systems. This initial
analysis suggests that the accelerated GIRK activation rate is
due primarily to the accelerated closing rate. Yet this conclu-
sion is confounded by the prediction that a greater kclose, with
unchanged kopen, would produce a profound reduction in
steady-state current amplitudes and a shift in the ACh dose-
response curve, which were not observed experimentally.
These kinetic anomalies are reminiscent of those encoun-
tered with the muscarinic m1 receptor-Gq-phospholipase C-b1
(PLC-b1)-signaling pathway that arise from the GTPase ac-
tivity of PLC-b1 (8, 30). A ‘‘quasi-stable’’ receptor-G protein-
effector complex has been proposed for this system (8, 30),
allowing Gq subunits to undergo multiple GTPase cycles while
associated with both receptor and effector (PLC-b1). This
molecular configuration favors an accelerated receptor-
catalyzed GDP3GTP exchange rate that is dependent on the
GTPase activity of PLC-b1, and permits otherwise unattain-
able steady-state levels of effector activation. Biochemical
evidence demonstrating the association of Ga(GDP)bg het-
erotrimers with the amino terminal domain of the Kir3.1
subunit (31) suggests the existence of an analogous m2 recep-
tor-G protein-GIRK channel complex (31, 32), of which RGS
proteins may be an important participant. The value for kopen
was not increased by RGS4, consistent with the view that this
parameter is governed by the rate of receptor-catalyzed GDP
FIG. 4. RGS4 expression in GIRK-transfected CHO cells elicits currents that mimic native atrial GIRK currents in their temporal gating
properties. (a Upper) Current traces from a rat atrial myocyte and from CHO cells transfected with the m2 receptor, Kir3.1, Kir3.2, and without
(control) or with (1RGS4) RGS4 cDNA. ACh (1 mM) was applied for 10 s. The time constant for solution changes was ,100 ms. (Scale bars 5
200 pA and 5 s.) Exponential fits to the current deactivation were used to derive tdeact. (Lower) Deactivation time constants (tdeact) for atrial (n 5
6) and CHO cells transfected with (n 5 22) or without (n 5 23) RGS4. (Bars 5 mean 6 SEM.) (b Upper) Activation phase of current traces for
cells exposed to increasing concentrations of ACh. Current amplitudes were normalized to the currents evoked at 10 mM ACh. (Lower) Summary
of the GIRK activation time constant (tact) as a function of ACh concentration obtained from at least four cells without (control) and with RGS4
coexpression (mean 6 SEM). The holding potential was 280 mV.
FIG. 5. Effects of RGS4 on GIRK current waveforms produced by
varying durations of m2 receptor activation. Current traces from
transfected CHO cells are as described in Fig. 4, exposed to 1 mM ACh
for 1, 5, and 20 s. Holding potential, 280 mV.
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3 GTP exchange (3). Although RGS4 does not affect the
GDP 3 GTP exchange rate for Ga(iyo) subunits in vitro (4),
its effect in the presence of activated receptors and effectors
has not yet been determined. We suggest that the discrepancy
between the kinetic and steady-state data provides functional
evidence for a complex among the m 2 receptor, Ga, RGS4,
Gbg, and the GIRK channel (31, 32).
Molecular Mechanisms Involved in GIRK Channel Gating.
Gbg dimers directly interact with both the Kir3.1 and Kir3.4
channel subunits (14, 31, 33, 34) that comprise the atrial GIRK
channel (21). These binding events are thought to activate the
channel by stabilizing an open-state conformation(s). G a
subunits also bind to GIRK subunits (31, 34), but do not
activate GIRK channels (12, 35) and in some cases inhibit
instead (36). The observations that RGS proteins accelerate
both GTP hydrolysis (4–6) and GIRK channel deactivation
provide strong support for the proposal that the deactivation
rate is determined by the GTP hydrolysis rate of G a(iyo)
subunits (11), and not by the much slower intrinsic rate of G bg
dissociation from the GIRK channel ( #0.003 s21 at 25°C, even
slower at 4°C) (14, 33). Perhaps the accelerated deactivation
involves interactions between G a-GDP and Gbg subunits
when both are directly bound to the channel, leading to
sequestration of Gbg more rapidly than would be provided by
intrinsic Gbg dissociation (12).
CONCLUSIONS
In our time-resolved measurements, RGS proteins exert an
effect on a Gbg effector (GIRK channels) that is primarily
kinetic, complementing and extending the observations of
negative regulation described for the yeast pheromone path-
way (2, 25) and for egg-laying behavior in C. elegans (3).
Responses to G protein-coupled receptors are generally clas-
sified as ‘‘neuromodulatory’’ processes that provide a means of
‘‘tuning’’ membrane excitability in response to specific input
stimuli (37). A large number of receptors in the nervous system
are coupled to Gaiyo pathways; and the present results show
how Ga(iyo)bg-coupled receptors can, with the aid of RGS
proteins, rapidly activate channels (and presumably other
effectors) and then rapidly deactivate them as well. These
temporal signaling properties are essential for establishing the
time course of GIRK-mediated hyperpolarizing postsynaptic
potentials that underlie certain forms of inhibitory synaptic
transmission (38, 39). It will be important to know how distinct
Ga(iyo)-coupled responses to specific receptors and effectors
(i.e., Ca21 channels) are shaped by individual members of the
growing RGS protein family.
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